UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nanobodies: New avenues for imaging, stabilizing and modulating GPCRs

Molecular and cellular endocrinology, 2019-03, Vol.484, p.15-24

2019

Volltextzugriff (PDF)

Optimizing the Safety and Efficacy of Bio-Radiopharmaceuticals for Cancer Therapy

Pharmaceutics, 2023-04, Vol.15 (5), p.1378

2023

Volltextzugriff (PDF)

The constitutive activity of the virally encoded chemokine receptor US28 accelerates glioblastoma growth

Oncogene, 2018-07, Vol.37 (30), p.4110-4121

2018

Volltextzugriff (PDF)

Nanobody-Targeted Photodynamic Therapy Selectively Kills Viral GPCR-Expressing Glioblastoma Cells

Molecular pharmaceutics, 2019-07, Vol.16 (7), p.3145-3156

2019

Volltextzugriff (PDF)

Targeting the latent human cytomegalovirus reservoir for T-cell-mediated killing with virus-specific nanobodies

Nature communications, 2021-07, Vol.12 (1), p.4436-4436, Article 4436

2021

Volltextzugriff (PDF)

Selective targeting of ligand-dependent and -independent signaling by GPCR conformation-specific anti-US28 intrabodies

Nature communications, 2021-07, Vol.12 (1), p.4357-4357, Article 4357

2021

Volltextzugriff (PDF)

Nanobody-based pannexin1 channel inhibitors reduce inflammation in acute liver injury

Journal of nanobiotechnology, 2023-10, Vol.21 (1), p.1-371, Article 371

2023

Volltextzugriff (PDF)

Generation and Characterization of Novel Pan‐Cancer Anti‐uPAR Fluorescent Nanobodies as Tools for Image‐Guided Surgery

Advanced science, 2024-08, Vol.11 (30), p.e2400700-n/a

2024

Volltextzugriff (PDF)

A few good reasons to use nanobodies for cancer treatment

European journal of immunology, 2023-09, Vol.53 (9), p.e2250024-e2250024

2023

Volltextzugriff (PDF)

Mechanisms Underlying Connexin Hemichannel Activation in Disease

International journal of molecular sciences, 2021-03, Vol.22 (7), p.3503

2021

Volltextzugriff (PDF)

Viral G Protein-Coupled Receptors: Attractive Targets for Herpesvirus-Associated Diseases

Pharmacological reviews, 2021-04, Vol.73 (2), p.828-846

2021

Volltextzugriff (PDF)

Scrutiny of chimeric antigen receptor activation by the extracellular domain: experience with single domain antibodies targeting multiple myeloma cells highlights the need for case-by-case optimization

Frontiers in immunology, 2024-04, Vol.15, p.1389018-1389018

2024

Volltextzugriff (PDF)

Nanobodies detecting and modulating GPCRs outside in and inside out

Current opinion in cell biology, 2019-04, Vol.57, p.115-122

2019

Volltextzugriff (PDF)

Imaging and therapeutic targeting of the tumor immune microenvironment with biologics

Advanced drug delivery reviews, 2022-05, Vol.184, p.114239-114239, Article 114239

2022

Volltextzugriff (PDF)

Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3

Molecular pharmacology, 2019-12, Vol.96 (6), p.753-764

2019

Volltextzugriff (PDF)

Current status and future expectations of nanobodies in oncology trials

Expert opinion on investigational drugs, 2023-08, Vol.32 (8), p.705-721

2023

Volltextzugriff (PDF)

Specific imaging of CD8 + T-Cell dynamics with a nanobody radiotracer against human CD8β

European journal of nuclear medicine and molecular imaging, 2024-09

2024

Volltextzugriff (PDF)

In Vitro Assessment of Binding Affinity, Selectivity, Uptake, Intracellular Degradation, and Toxicity of Nanobody-Photosensitizer Conjugates

Methods in molecular biology (Clifton, N.J.), 2022, Vol.2451, p.505

2022

Volltextzugriff (PDF)

Development and evaluation of nanobody tracers for noninvasive nuclear imaging of the immune-checkpoint TIGIT

Frontiers in immunology, 2023-09, Vol.14, p.1268900-1268900

2023

Volltextzugriff (PDF)

AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia

Theranostics, 2024-01, Vol.14 (7), p.2656-2674

2024

Volltextzugriff (PDF)

Therapeutic Nanobodies Targeting Cell Plasma Membrane Transport Proteins: A High-Risk/High-Gain Endeavor

Biomolecules (Basel, Switzerland), 2021-01, Vol.11 (1), p.63

2021

Volltextzugriff (PDF)

Emerging applications of nanobodies in cancer therapy

International review of cell and molecular biology, 2022, Vol.369, p.143-199

2022

Volltextzugriff (PDF)

Advancements in nuclear imaging using radiolabeled nanobody tracers to support cancer immunotherapy

Immunotherapy advances, 2024, Vol.4 (1), p.ltae006

2024

Volltextzugriff (PDF)

Abstract 4181: AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in acute myeloid leukemia

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.4181-4181

2024

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(23)
Buchkapitel
(1)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Life Sciences & Biomedicine
(19)
Nanobodies
(10)
Humans
(8)
Animals
(6)
Cancer
(6)
Pharmacology & Pharmacy
(6)
Proteins
(6)
Antibodies
(5)
Immunology
(5)
Biochemistry & Molecular Biology
(4)
Science & Technology - Other Topics
(4)
Single-Domain Antibodies - Metabolism
(4)
Single-Domain Antibodies - Pharmacology
(4)
Therapy
(4)
Adenosine Triphosphate
(3)
Cancer Therapies
(3)
Care And Treatment
(3)
Cell Biology
(3)
Cell Line, Tumor
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Nanobodies: New avenues for imaging, stabilizing and modulating GPCRs

Optimizing the Safety and Efficacy of Bio-Radiopharmaceuticals for Cancer Therapy

The constitutive activity of the virally encoded chemokine receptor US28 accelerates glioblastoma growth

Nanobody-Targeted Photodynamic Therapy Selectively Kills Viral GPCR-Expressing Glioblastoma Cells

Targeting the latent human cytomegalovirus reservoir for T-cell-mediated killing with virus-specific nanobodies

Selective targeting of ligand-dependent and -independent signaling by GPCR conformation-specific anti-US28 intrabodies

Nanobody-based pannexin1 channel inhibitors reduce inflammation in acute liver injury

Generation and Characterization of Novel Pan‐Cancer Anti‐uPAR Fluorescent Nanobodies as Tools for Image‐Guided Surgery

A few good reasons to use nanobodies for cancer treatment

Mechanisms Underlying Connexin Hemichannel Activation in Disease

Viral G Protein-Coupled Receptors: Attractive Targets for Herpesvirus-Associated Diseases

Scrutiny of chimeric antigen receptor activation by the extracellular domain: experience with single domain antibodies targeting multiple myeloma cells highlights the need for case-by-case optimization

Nanobodies detecting and modulating GPCRs outside in and inside out

Imaging and therapeutic targeting of the tumor immune microenvironment with biologics

Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3

Current status and future expectations of nanobodies in oncology trials

Specific imaging of CD8 + T-Cell dynamics with a nanobody radiotracer against human CD8β

In Vitro Assessment of Binding Affinity, Selectivity, Uptake, Intracellular Degradation, and Toxicity of Nanobody-Photosensitizer Conjugates

Development and evaluation of nanobody tracers for noninvasive nuclear imaging of the immune-checkpoint TIGIT

AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia

Therapeutic Nanobodies Targeting Cell Plasma Membrane Transport Proteins: A High-Risk/High-Gain Endeavor

Emerging applications of nanobodies in cancer therapy

Advancements in nuclear imaging using radiolabeled nanobody tracers to support cancer immunotherapy

Abstract 4181: AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in acute myeloid leukemia

Suchergebnisse filtern